Moderna appoints Abbas Hussain, ex-CEO of Vifor Pharma, to Board of Directors

Moderna, Inc.

Hussain appointed effective Oct 2, 2024; board size fixed at nine directors.
He brings over 35 years of healthcare leadership, including former CEO of Vifor Pharma and Global President of GSK Pharmaceuticals & Vaccines.
Hussain will serve on the Audit Committee and receive standard non-employee director compensation plus initial and pro-rata annual equity grants.
No arrangements or relationships requiring disclosure under Item 404(a) of Regulation S-K.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Abbas Hussain

Director

MRNA · Moderna, Inc.

Effective: 2024-10-02
Filed: October 2, 2024, 7:59 PM ET

On September 28, 2024, the Board of Directors (the “Board”) of Moderna, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Abbas Hussain to the Board, effective October 2, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Abbas Hussain was appointed as Director at Moderna, Inc..

Action: appointed
Role: Director

Exact text from the filing

On September 28, 2024, the Board of Directors (the “Board”) of Moderna, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Abbas Hussain to the Board, effective October 2, 2024.

View on SEC.gov

Moderna, Inc. filing history →

Source: SEC EDGAR

accession 0001682852-24-000052

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.